Physiological properties of conjugated linoleic acid and implications for human health

Nutrition in Clinical Practice

Volumn 21, Issue 4, 2006, Pages 367-373

  Badinga, Lokenga ^a   Greene, Elizabeth S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; CONJUGATED LINOLEIC ACID;

ANIMAL; BODY COMPOSITION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; HUMAN; ISOMERISM; LIPID METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-OBESITY AGENTS; ANTICARCINOGENIC AGENTS; ANTILIPEMIC AGENTS; BODY COMPOSITION; DISEASE MODELS, ANIMAL; HUMANS; ISOMERISM; LINOLEIC ACIDS, CONJUGATED; LIPID METABOLISM;

EID: 34547892225     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426506021004367     Document Type: Review

References (73)

1. Riekert R, Steinhart H, Frische J, et al. Enhanced resolution of conjugated linoleic acid isomers by tandem-column silver ion high performance liquid chromatography. J High Resolution Chro-matogr. 1999;22:144-148.
2. Chin SF, Storkson JM, Ha YL, Pariza M. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Compos Anal. 1992;5:185-197.
3. Bauman DE, Baumgard LH, Corl BA, Griinari JM. Biosynthesis of conjugated linoleic acid in ruminants. Proc Am Soc Anim Sci. 1999;1-15.
4. Gaulier J-M, Berven G, Blankson H, Gudmundsen O. Clinical trials support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids. 2002;37:1019-1025.
5. Park Y, Albright K, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997;32:853-858.
6. Park Y, Albright KJ, Storkson JM, Liu W, Cook ME, Pariza MW. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids. 2001;34:243-248.
7. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999;34:235-241.
8. Sisk MB, Hausman DB, Martin RJ, Azain MJ. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J Nutr. 2001;131:1668-1674.
9. Szymczyk B, Pisulewski P, Szczurek W, Hanczakowski P. The effects of feeding conjugated linoleic acid (CLA) on rat growth performance, serum lipoproteins and subsequent lipid composition of selected tissues. J Sci Food Agric. 2000;80:1553-1558.
10. Lee KN, Kritchevsky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis. 1994;108:19-25.
11. Atkinson RL. Conjugated linoleic acid for altering body composition and treating obesity. In: Yurawecz MP, Mossoba MM, Kramer JKG, eds. Advances in Conjugated Linoleic Acid Research. Champaign, IL: AOCS Press; 1999:328-353.
12. Zambell KL, Keim NL, Van Loan MD, et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids. 2000;35:777-782.
13. Blankson H, Stakkestad JA, Fagertun H, Thorn E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000;130:2943-2948.
14. Evans M, Pariza MW, Park Y, Curtis L, Kuebler B, Mcintosh M. Trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator-activated receptor-γ2 and aP2 expression in 3T3-L1 preadipo-cytes. Lipids. 2000;36:1223-1232.
15. Tsuboyama-Kasaoka M, Takahashi M, Tanemura K, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000;49: 1534-1542.
16. Belury MA, Kempa-Steczko A. Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids. 1997;32:199-204.
17. 2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids. 1998;33:417-425.
18. Badinga L, Selberg KT, Dinges AC, Comer CW, Miles RD. Dietary conjugated linoleic acid alters hepatic lipid content and. fatty acid composition in broiler chickens. Poultry Sci. 2003;82:111-116.
19. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr. 2002;22: 505-531.
20. Park Y, McGuire MK, Behr R, McGuire MA, Evans MA, Schultz TD. High fat dairy product consumption increases delta 9e,llt-18:2 (rumenic acid) and total lipid concentrations of human milk. Lipids. 1999;34:543-549.
21. Mougios V, Matsakas A, Petridou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem. 2001;12:585-594.
22. Iversen SA, Cawood PM, Madigan J, Lawson AM, Dormandy TL. Identification of a diene conjugated component of human lipid as octadeca-9,ll-dienoic acid. FEBS Lett. 1984;171:320-324.
23. Dormandy TL, Wickens DG. The experimental and clinical pathway of diene conjugation. Chem Phys Lipids. 1987;45: 353-364.
24. Fogerty AC, Ford GL, Svoronos D. Octadeca-9,ll-dienoic acid in foodstuffs and in the lipids of human blood and breast milk. Nutr Rep Int. 1988;38:937-944.
25. Britton M, Fong C, Wickens D, Yudkin J. Diet as a source of phospholipids esterified 9,11-octadecadienoic acid in humans. Clin Sci. 1992;83:97-101.
26. Sugano M, Tsujita A, Yamasaki M, Yamada K, Ikeda I, Kritchevsky D. Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem. 1997; 8:38-43.
27. Jiang J, Wolk A, Vessby B. Relationship between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am J Clin Nutr. 1999;70:21-27.
28. Turpeinen AM, Mutanen M, Aro A, et al. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr. 2002;76:504-510.
29. Sirri F, Tallarico N, Meluzzi A, Franchini A. Fatty acid composition and production traits of broiler fed diets containing conjugated linoleic acid. Poultry Sci. 2003;82:1356-1361.
30. Chouinard PY, Corneau L, Barbano DM, Metzger LE, Bauman DE. Conjugated linoleic acids alter milk fatty acid composition and inhibit milk fat secretion in dairy cows. J Nutr. 1999;129: 1579-1584.
31. Bee G. Dietary conjugated linoleic acid composition during pregnancy and lactation influences growth and tissue composition in weaned pigs. J Nutr. 2000;130:2981-2989.
32. Lee K, Pariza MW, Ntambi JM. Conjugated linoleic acid decreases hepatic steroyl-CoA desaturase mRNA expression. Biochem Biophys Res Commun. 1998;248:817-821.
33. Choi Y, Kim Y-C, Han Y-B, Park Y, Pariza MW, Ntambi JM. The trans-10,cis-12 isomer of conjugated linoleic acid downregulates steroyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J Nutr. 2000;130:1920-1924.
34. Park Y, Storkson JM, Ntambi JM, Cook ME, Sih CJ, Pariza MW. Inhibition of hepatic steroyl-CoA desaturase activity by trans-10,cis-12 conjugated linoleic acid and its derivatives. Biochem Biophys Acta. 2000;1486:285-292.
35. Baumgard LH, Sangster JK, Bauman DE. Milk fat synthesis in dairy cows is progressively reduced by increasing supplemental amounts of trans-10,cis-12 conjugated linoleic acid (CLA). J Nutr. 2001;131:1764-1769.
36. Loor JJ, Herbein JH. Exogenous conjugated linoleic acid isomers reduce bovine milk fat concentration and yield by inhibiting de novo fatty acid synthesis. J Nutr. 1998; 128: 2411-2419.
37. Baumgard LH, Corl BA, Dwyer DA, Saebo A, Bauman DE. Identification of the conjugated linoleic acid isomer that inhibits milk fat synthesis. Am J Physiol Regulat Integr Comp Physiol. 2000;278:R179-R184.
38. Ritzenthaler KL, McGuire MK, McGuire MA, et al. Consumption of conjugated linoleic acid (CLA) from CLA-enriched cheese does not alter milk fat or immunity in lactating women. J Nutr. 2005;135:422-430.
39. Masters N, McGuire MA, Beerman KA, Dasgupta N, McGuire MK. Maternal supplementation with CLA decreases milk fat in humans. Lipids. 2002;37:133-138.
40. Baumgard LH, Matitashvili E, Corl BA, Dwyer DA, Bauman DE. Trans-10,cis-12 conjugated linoleic acid decreases lipogenic rates and expression of genes involved in milk lipid synthesis in dairy cows. J Dairy Sci. 2002;85:2155-2163.
41. 2 production and hyperplasia in mouse epidermis. Nutr Cancer. 1999;33:132-138.
42. Harris MA, Hansen RA, Vidsudhiphan P, et al. Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metal-loproteinase production. Prostaglandins Leukot Essent Fatty acids. 2001;65:23-29.
43. Urquhart P, Parkin SM, Rogers JS, Bosley JA, Nicolaou A. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim Biophys Acta. 2002;1580:150-160.
44. Badinga L, Dinges AC, Silvestre M-J. Conjugated linoleic acid attenuates phorbol ester-induced prostaglandin production in bovine endometrial cells [abstract]. Biol Reprod. 2003;68:227.
45. Kelley GS. Conjugated linoleic acid: a review. Altera Med Rev. 2001;6:367-382.
46. Rainer L, Heiss CJ. Conjugated linoleic acid: health implications and effects on body composition. J Am Diet Assoc. 2004;104:963-968.
47. Whigham LD, Cook ME, Atkinson RL. Conjugated linoleic acid: implications for human health. Pharmacol Res. 2000;42: 503-510.
48. Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivatives of linoleic acid. Cancer Res. 1991;15:6118-6124.
49. Ip C, Lisk DJ, Scimeca JA. Potential of food modification in cancer prevention. Cancer Res. 1994;54(suppl):1957S-1959S.
50. Ip C, Briggs SP, Haegele AD, Thompson HJ, Storkson J, Scimeca JA. The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. Carcinogenesis. 1996;17:1045-1050.
51. Thompson H, Zhu Z, Banni S, Darcy K, Loftus T, Ip C. Morphological and biochemical status of mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. Cancer Res. 1997;57:5067-5072.
52. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994;54:1212-1215.
53. Banni S, Angioni E, Casu V, et al. An increase in vitamin A status by the feeding of conjugated linoleic acid. Nutr Cancer. 1999;33: 53-57.
54. Pariza MW, Park Y, Cook ME. Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci. 1999;52:107-110.
55. Belury MA, Moya-Camarena SY, Liu KL, Vanden Heuvel JP. Dietary conjugated linoleic acid induces peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J Nutr Biochem. 1997;8:579-584.
56. Moya-Camarena SY, Vanden Heuvel JP, Belury MA. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochem Biophys Acta. 1999;1436:331-342.
57. Martin J-C, Gregoire S, Siess M-H, et al. Effects of conjugated linoleic acid isomers on lipid-metabolizing enzymes in male rats. Lipids. 2000;35:91-98.
58. Miller RA. Aging and immune function: cellular and biochemical analyses. Exp Gerontol. 1994;29:21-35.
59. Furukawa T, Meydani SN, Blumberg JB. Reversal of age-associated decline in immune responsiveness by dietary glutathione supplementation in mice. Mech Ageing Dev. 1987;38: 107-117.
60. Wu D, Meydani SN, Sastre J, Hayek M, Meydani M. In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects. J Nutr. 1994;124:655-663.
61. Beharka AA, Wu D, Han SN, Meydani SN. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Mech Ageing Dev. 1997;94:157-165.
62. Cook ME, Miller CC, Park Y, Pariza MW. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poultry Sci. 1993;72:1301-1305.
63. Hayek MG, Han SN, Wu D, et al. Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrlBR mice. J Nutr. 1999;129:32-38.
64. Pariza MW, Park Y, Cook ME. Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci. 1999;52:1007-1024.
65. Changhua L, Jindong Y, Defa L, Lidan Z, Shiyan Q, Jianjun X. Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr. 2005;135:239-244.
66. Yu Y, Correl PH, Vanden Heuvel JP. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARy-dependent mechanism. Biochim Biophys Acta. 2002;1581:89-99.
67. Wilson TA, Nicolosi RJ, Chrysam M, Kritchevsky D. Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutr Res. 2000; 20:1795-1805.
68. Parodi PW. Conjugated linoleic acid. Food Australia. 2002;54:96-99.
69. Yotsumoto H, Hara E, Naka S, Adlof RO, Emken EA, Yanagita T. lOtrans, 12cis-linoleic acid reduces apolipoprotein B secretion in HeG2 cells. Food Res Int. 1999;31:403-409.
70. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary translO, cisl2 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25:1516-1521.
71. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov H, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002;106:1925-1929.
72. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999;276:1172-1179.
73. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa I fa rat. Biochem Biophys Res Commun. 1998;244:678-682.